CFR section

21 CFR 812.110(a): Specific responsibilities of investigators

PART 812-INVESTIGATIONAL DEVICE EXEMPTIONS · Subpart E-Responsibilities of Investigators

Key facts

Citation 21 CFR 812.110(a)
Section Specific responsibilities of investigators
Part PART 812-INVESTIGATIONAL DEVICE EXEMPTIONS
Subpart Subpart E-Responsibilities of Investigators
Subchapter 21 CFR H Medical Devices
Product types cited Devices, General
Regulation text (excerpt) (a) Awaiting approval. An investigator may determine whether potential subjects would be interested in participating in an investigation, but shall not request the written informed consent of any subject to participate, and shall not allow any subject to participate before obtaining IRB and FDA approval.

At a glance

  • 10–99 Inspections citing this section
  • 1–9 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA